medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2017, Number 3

<< Back Next >>

Acta Med 2017; 15 (3)

Acute coronary syndrome due to carbon monoxide and response to hyperbaric oxygen therapy

Pérez TJG, Bautista AMI, Moranchel GL, Martiñón RR, Hernández AM

Language: Spanish
References: 13
Page: 230-233
PDF size: 148.96 Kb.


ABSTRACT

Carbon monoxide (CO) is an odorless, colorless gas that owes its asphyctic effects to its affinity for carrier proteins such as hemoglobin (Hb). It is formed during the incomplete combustion of any carbon containing compound. CO poisoning is a major cause of neurological damage and death around the world, because it primarily affects the organs with the highest oxygen demand. Hyperbaric oxygen therapy (HBO) is the first line treatment for CO poisoning and the only way to prevent development of sequelae in patients with hypoxia. We report a case of a woman with accidental exposure to CO who developed a coronary acute syndrome (CAS), which was successfully treated with HBO.


REFERENCES

  1. Hampson NB, Piantadosi CA, Weaver LK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012; 186 (118): 1095-1101.

  2. Guzman JA. Carbon monoxide poisoning. Crit Care Clin. 2012; 28: 537-548.

  3. Chiew AL, Buckley NA. Carbon monoxide poisoning in the 21st century. Crit Care. 2014; 18 (2): 221-228.

  4. Prockop LD, Chichkova RI. Carbon monoxide intoxication: an updated review. J Neurol Sci. 2007; 262: 122-130.

  5. Andresen MC, Doyle MW, Jin YH, Bailey TW. Cellular mechanisms of baroreceptor integration at the nucleus tractus solitarius. Ann N Y Acad Sci. 2001; 940: 132-141.

  6. Gandini C, Castoldi AF, Candura SM, Locatelli C, Butera R, Priori S et al. Carbon monoxide cardiotoxicity. J Toxicol Clin Toxicol. 2001; 39: 35-44.

  7. Wolf SJ, Lavonas EJ, Sloan EP, Jagoda AS. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Ann Emerg Med. 2008; 51: 138-152.

  8. Harper A, Croft-Baker J. Carbon monoxide poisoning: undetected by both patients and their doctors. Age and Ageing. 2004; 33: 105-109.

  9. Iqbal S, Clower JH, Boehmer TK, Yip FY, Garbe P et al. Carbon monoxide-related hospitalizations in the U.S.: evaluation of a web-based query system for public health surveillance. Public Health Rep. 2010; 125: 423-432.

  10. Jung Y, Lee J, Min Y, Yip FY, Garbe P. Carbon monoxide-induced cardiomyopathy. Epidemiology, clinical characteristics and prognosis. Circ J. 2014; 78: 1437-1444.

  11. Aslan S, Erol MK, Karcioglu O, Meral M, Cakir Z, Katirci Y. The investigation of ischemic myocardial damage in patients with carbon monoxide poisoning. Anadolu Kardiyol Derg. 2005; 5: 189-193.

  12. Satran D, Henry CR, Adkinson C, Nicholson CN, Bracha Y, Henry TD. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol. 2005; 45: 1513-1516.

  13. Kalay N, Ozdogru I, Cetinkaya Y, Eryol NK, Dogan A, Gul I et al. Cardiovascular effects of carbon monoxide poisoning. Am J Cardiol. 2007; 99: 322-324.




2020     |     www.medigraphic.com